The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Combining ipilimumab (ipi) and nivolumab (nivo) in advanced melanoma following progression on a PD-1 inhibitor (SWOG S1616).
 
Ari M. Vanderwalde
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Genentech/Roche
Research Funding - Amgen; AstraZeneca; Bristol-Myers Squibb; Genentech/Roche; Lilly; Merck; Millennium; Polynoma
Travel, Accommodations, Expenses - Caris Life Sciences
 
Michaella Latkovic-Taber
No Relationships to Disclose
 
Siwen Hu-Lieskovan
Consulting or Advisory Role - Amgen; Genmab; Merck
Research Funding - Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Nektar (Inst); Neon Therapeutics (Inst); Pfizer (Inst); Plexxikon (Inst); Vaccinex (Inst)
 
Kenneth F. Grossmann
Consulting or Advisory Role - Bristol-Myers Squibb (I); Castle Biosciences; Roche/Genentech
 
Jeffrey Alan Sosman
Honoraria - Amgen; Array BioPharma; Bristol-Myers Squibb; Merck
Consulting or Advisory Role - Amgen; Array BioPharma; Bristol-Myers Squibb; Merck
 
Danae Campos
Employment - QTC Management- A Leidos Company
Travel, Accommodations, Expenses - QTC Management- A Leidos Company
 
Michael Wu
No Relationships to Disclose
 
Antoni Ribas
Stock and Other Ownership Interests - Advaxis; Arcus Biosciences; Compugen; CytomX Therapeutics; Five Prime Therapeutics; FLX Bio; PACT Pharma; Tango Therapeutics
Consulting or Advisory Role - Amgen; Genentech/Roche; Merck; Novartis